The DOI matches its Crossref record; 189 of the 189 references it cites were found in a registry or an index.
Big data in basic and translational cancer research
Open accessAbstract
Historically, the primary focus of cancer research has been molecular and clinical studies of a few essential pathways and genes. Recent years have seen the rapid accumulation of large-scale cancer omics data catalysed by breakthroughs in high-throughput technologies. This fast data growth has given rise to an evolving concept of 'big data' in cancer, whose analysis demands large computational resources and can potentially bring novel insights into essential questions. Indeed, the combination of big data, bioinformatics and artificial intelligence has led to notable advances in our basic understanding of cancer biology and to translational advancements. Further advances will require a concerted effort among data scientists, clinicians, biologists and policymakers. Here, we review the current state of the art and future challenges for harnessing big data to advance cancer research and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The advancement of omics data due to breakthroughs in high-throughput technologies has generated the concept of “big data” in cancer, the analysis of which necessitates large computational resources and bioinformatic algorithms [7].”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
The Elements of Statistical Learning
Hastie, T., Friedman, J., & Tibshirani, R. (2001) · Springer Series in Statistics · doi:10.1007/978-0-387-21606-5 · Cited by 24,162
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Integrated analysis of multimodal single-cell data
Hao, Y., Hao, S., Andersen-Nissen, E., Mauck, W. M., Zheng, S., Butler, A., Lee, M. J., Wilk, A. J., Darby, C., Zagar, M., et al. (2020) · doi:10.1101/2020.10.12.335331 · Cited by 15,508
Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
Robust enumeration of cell subsets from tissue expression profiles
Newman, A. M., Liu, C. L., Green, M. R., Gentles, A. J., Feng, W., Xu, Y., Hoang, C. D., Diehn, M., & Alizadeh, A. A. (2015) · Nature Methods · doi:10.1038/nmeth.3337 · Cited by 13,224
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
Research works printed but not linked: 1
- Raghu, M., Zhang, C., Kleinberg, J. & Bengio, S. Transfusion: understanding transfer learning for medical imaging. Adv. Neural Inf. Process. Syst. 33, 3347–3357 (2019).
Cited by
Sorted by citations
Artificial intelligence for digital and computational pathology
Song, A. H., Jaume, G., Williamson, D. F. K., Lu, M. Y., Vaidya, A., Miller, T. R., & Mahmood, F. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00096-8 · Cited by 356
Baião, A. R., Cai, Z., Poulos, R. C., Robinson, P. J., Reddel, R. R., Zhong, Q., Vinga, S., & Gonçalves, E. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf355 · Cited by 274
Biomarkers for immunotherapy of hepatocellular carcinoma
Greten, T. F., Villanueva, A., Korangy, F., Ruf, B., Yarchoan, M., Ma, L., Ruppin, E., & Wang, X. W. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00816-4 · Cited by 227
Self-citationAssessing and mitigating batch effects in large-scale omics studies
Yu, Y., Mai, Y., Zheng, Y., & Shi, L. M. (2024) · Genome biology · doi:10.1186/s13059-024-03401-9 · Cited by 254
Advances in molecular pathology and therapy of non-small cell lung cancer
Huang, Q., Li, Y., Huang, Y., Wu, J., Bao, W., Xue, C., Li, X., Dong, S., Dong, Z., & Hu, S. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02243-6 · Cited by 197
Multimodal data integration for oncology in the era of deep neural networks: a review
Waqas, A., Tripathi, A., Ramachandran, R. P., Stewart, P. A., & Rasool, G. (2024) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2024.1408843 · Cited by 165
Advancing CAR T cell therapy through the use of multidimensional omics data
Yang, J., Chen, Y., Jing, Y., Green, M. R., & Han, L. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00729-2 · Cited by 130
Mao, Y., Shangguan, D., Huang, Q., Xiao, L., Cao, D., Zhou, H., & Wang, Y. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02321-x · Cited by 90
Matsuoka, T., & Yashiro, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115880 · Cited by 83
“…has generated the concept of “big data” in cancer, the analysis of which necessitates large computational resources and bioinformatic algorithms [7]. large computational technology, a comprehensive understanding With the interpretation of bioinformatics technology, a comprehensive understanding…”
BackgroundOmics-Based Investigations of Breast Cancer
Neagu, A.-N., Whitham, D., Bruno, P. S., Morrissiey, H., Darie, C. A., & Darie, C. C. (2023) · Molecules · doi:10.3390/molecules28124768 · Cited by 81
Big data and artificial intelligence in cancer research
Wu, X., Li, W., & Tu, H. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.10.006 · Cited by 83
Computational approaches to modelling and optimizing cancer treatment
McDonald, T. O., Cheng, Y.-C., Graser, C. J., Nicol, P. B., Temko, D., & Michor, F. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00089-7 · Cited by 83
Poursaeed, R., Mohammadzadeh, M., & Safaei, A. A. (2024) · BMC Cancer · doi:10.1186/s12885-024-13320-4 · Cited by 76
Hallmarks of artificial intelligence contributions to precision oncology
Chang, T., Park, S., Schäffer, A. A., Jiang, P., & Ruppin, E. (2025) · Nature Cancer · doi:10.1038/s43018-025-00917-2 · Cited by 83
Self-citationDhanka, S., Sharma, A., Kumar, A., Maini, S., & Vundavilli, H. (2025) · Archives of Computational Methods in Engineering · doi:10.1007/s11831-025-10309-5 · Cited by 87
Ahmed, F., Samantasinghar, A., Soomro, A. M., Kim, S., & Choi, K. H. (2023) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2023.104373 · Cited by 78
A multi-omics approach to reveal critical mechanisms of activator protein 1 (AP-1)
Li, F., Tian, J., Zhang, L., He, H., & Song, D. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117225 · Cited by 72
Biswas, A., Kumari, A., Gaikwad, D. S., & Pandey, D. K. (2023) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2023.0197 · Cited by 56
Cancer immunology data engine reveals secreted AOAH as a potential immunotherapy
Gong, L., Luo, J., Yang, E., Ru, B., Qi, Z., Yang, Y., Rani, A., Purohit, A., Zhang, Y., Guan, G., et al. (2025) · Cell · doi:10.1016/j.cell.2025.07.004 · Cited by 56
Self-citationProgress and Perspective of CRISPR‐Cas9 Technology in Translational Medicine
Zheng, R., Zhang, L., Parvin, R., Su, L., Chi, J., Shi, K., Ye, F., & Huang, X. (2023) · Advanced Science · doi:10.1002/advs.202300195 · Cited by 56
scDiffusion: conditional generation of high-quality single-cell data using diffusion model
Luo, E., Hao, M., Wei, L., & Zhang, X. (2024) · Bioinformatics · doi:10.1093/bioinformatics/btae518 · Cited by 66
Artificial Intelligence in Public Health: Current Trends and Future Possibilities
Giansanti, D. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191911907 · Cited by 46
Jose, A., Kulkarni, P., Thilakan, J., Munisamy, M., Malhotra, A. G., Singh, J., Kumar, A., Rangnekar, V. M., Arya, N., & Rao, M. (2024) · Molecular Cancer · doi:10.1186/s12943-023-01916-6 · Cited by 49
Functional Materials for Subcellular Targeting Strategies in Cancer Therapy: Progress and Prospects
Cheng, Y., Qu, Z., Jiang, Q., Xu, T., Zheng, H., Ye, P., He, M., Tong, Y., Ma, Y., & Bao, A. (2023) · Advanced Materials · doi:10.1002/adma.202305095 · Cited by 43
Little, R. D., Jayawardana, T. C., Koentgen, S., Zhang, F., Connor, S. J., Boussioutas, A., Ward, M. G., Gibson, P. R., Sparrow, M., & Hold, G. L. (2024) · eGastroenterology · doi:10.1136/egastro-2023-100006 · Cited by 42
Malapelle, U., Leighl, N. B., Addeo, A., Hershkovitz, D., Hochmair, M. J., Khorshid, O., Länger, F. P., de Marinis, F., Peled, N., Sheffield, B. S., et al. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02709-4 · Cited by 39
Luo, T., Fan, Z., Zeng, A., Wang, A., Pan, Y., Xu, Y., Chen, H., Chen, W., Nie, D., Lin, J., et al. (2024) · Advanced Science · doi:10.1002/advs.202410427 · Cited by 38
Advancing breast, lung and prostate cancer research with federated learning. A systematic review
Ankolekar, A., Boie, S. D., Abdollahyan, M., Gadaleta, E., Hasheminasab, S. A., Yang, G., Beauville, C., Δικαίος, Ν., Kastis, G. A., Bussmann, M., et al. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01591-5 · Cited by 44
Immune Resistance Mechanisms and the Road to Personalized Immunotherapy
Piper, M., Kluger, H. M., Ruppin, E., & Hu‐Lieskovan, S. (2023) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_390290 · Cited by 34
Self-citationLipocalin-2: A Nurturer of Tumor Progression and a Novel Candidate for Targeted Cancer Therapy
Živalj, M., Ginderachter, J. A. V., & Stijlemans, B. (2023) · Cancers · doi:10.3390/cancers15215159 · Cited by 35
Hum, M., & Lee, A. S. G. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06495-2 · Cited by 35
Gorman, C., Punzo, D., Octaviano, I., Pieper, S. D., Longabaugh, W. J. R., Clunie, D., Kikinis, R., Fedorov, A., & Herrmann, M. D. (2023) · Nature Communications · doi:10.1038/s41467-023-37224-2 · Cited by 36
Computational Biology Helps Understand How Polyploid Giant Cancer Cells Drive Tumor Success
Casotti, M. C., Meira, D., Zetum, A., de Araújo, B. C., da Silva, D. R. C., dos Santos, E. D. V. W., Garcia, F. M., de Paula, F., Santana, G. M., Louro, L. S., et al. (2023) · Genes · doi:10.3390/genes14040801 · Cited by 28
Zheng, L., Shi, S., Sun, X., Lu, M., Liao, Y., Zhu, S., Zhang, H., Pan, Z., Fang, P., Zeng, Z., et al. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae006 · Cited by 34
Heat-Shock Proteins in Leukemia and Lymphoma: Multitargets for Innovative Therapeutic Approaches
Gibouin, V. C., Durand, M., Quéré, R., Girodon, F., Garrido, C., & Jégo, G. (2023) · Cancers · doi:10.3390/cancers15030984 · Cited by 33
CT radiomics-based biomarkers can predict response to immunotherapy in hepatocellular carcinoma
Qi, L., Zhu, Y., Li, J., Zhou, M., Liu, B., Chen, J., & Shen, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-70208-w · Cited by 29
Applications of Multimodal Artificial Intelligence in Non-Hodgkin Lymphoma B Cells
Isavand, P., Aghamiri, S. S., & Amin, R. (2024) · Biomedicines · doi:10.3390/biomedicines12081753 · Cited by 24
GC-CDSS: Personalized gastric cancer treatment recommendations system based on knowledge graph
Li, S., Li, Z., Xue, K., Zhou, X., Ding, C., Shao, Y., Zhang, S., Ruan, T., Zheng, M., & Sun, J. (2024) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2024.105402 · Cited by 23
Knowledge-Informed Machine Learning for Cancer Diagnosis and Prognosis: A Review
Mao, L., Wang, H., Hu, L., Tran, N. L., Canoll, P., Swanson, K. R., & Li, J. (2024) · IEEE Transactions on Automation Science and Engineering · doi:10.1109/tase.2024.3515839 · Cited by 25
Novel insights into HBV‐hepatocellular carcinoma at single‐cell sequencing
Yin, D., Zhou, T., Xia, X., Chang, H., Liu, Z., Li, Q., Shu, Y., & Xu, H. (2023) · MedComm – Oncology · doi:10.1002/mog2.60 · Cited by 23
Santangelo, G., Nicora, G., Bellazzi, R., & Dagliati, A. (2025) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-024-02731-9 · Cited by 26
Krepper, D., Cesari, M., Hubel, N. J., Zelger, P., & Sztankay, M. J. (2024) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-024-00808-7 · Cited by 22
Multi-omics pan-cancer analyses identify MCM4 as a promising prognostic and diagnostic biomarker
Li, Y., Gao, W., Yang, Z., Hu, Z., & Li, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-57299-1 · Cited by 17
Adaptive Cancer Therapy in the Age of Generative Artificial Intelligence
Derbal, Y. (2024) · Cancer Control · doi:10.1177/10732748241264704 · Cited by 17
Prediction of ECOG Performance Status of Lung Cancer Patients Using LIME-Based Machine Learning
Nguyen, H. V., & Byeon, H. (2023) · Mathematics · doi:10.3390/math11102354 · Cited by 15
From cancer big data to treatment: Artificial intelligence in cancer research
Danishuddin, M., Khan, S., & Kim, J.-J. (2023) · The Journal of Gene Medicine · doi:10.1002/jgm.3629 · Cited by 16
Computational model for disease research
Chen, X., & Li, H. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbac615 · Cited by 16
Chota, A., Abrahamse, H., & George, B. P. A. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118710 · Cited by 15
A Knowledge‐Guided Graph Learning Approach Bridging Phenotype‐ and Target‐Based Drug Discovery
Ye, Q., Zeng, Y., Jiang, L., Kang, Y., Pan, P., Chen, J., Deng, Y., Zhao, H., He, S., Hou, T., et al. (2025) · Advanced Science · doi:10.1002/advs.202412402 · Cited by 16
Expression And Prognostic Role of PRDX1 In Gastrointestinal Cancers
Zhang, Z., Zhou, P., Liu, M., & Pei, B. (2023) · Journal of Cancer · doi:10.7150/jca.86568 · Cited by 14
Overcoming Resistance to Standard-of-Care Therapies for Head and Neck Squamous Cell Carcinomas
Gauss, C., Stone, L. D., Ghafouri, M., Quan, D. L., Johnson, J., Fribley, A. M., & Amm, H. M. (2024) · Cells · doi:10.3390/cells13121018 · Cited by 14
Omics in acute‐on‐chronic liver failure
Li, P., Liang, X., Luo, J., & Li, J. (2023) · Liver International · doi:10.1111/liv.15634 · Cited by 15
Ten challenges and opportunities in computational immuno-oncology
Bao, R., Hutson, A. D., Madabhushi, A., Jönsson, V. D., Rosario, S. R., Barnholtz‐Sloan, J. S., Fertig, E. J., Marathe, H. G., Harris, L. N., Altreuter, J., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-009721 · Cited by 14
Self-citationZuo, K., Zhong, Z., Huang, P., Tang, S., Chen, Y., & Jiang, Y. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.03.657521 · Cited by 13
Alshorman, J., Mehran, M. J., Bahrami, Y., Mohammadzadeh, S., Barzigar, R., Morshedi, M., Haider, K. H., Tembo, K. M., Rong, S.-J., Jadgal, N., et al. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-026-02107-5 · Cited by 15
Trans-activating mutations of the pseudokinase ERBB3
Koivu, M. K. A., Chakroborty, D., Airenne, T. T., Johnson, M. S., Kurppa, K. J., & Elenius, K. (2024) · Oncogene · doi:10.1038/s41388-024-03070-9 · Cited by 12
Heesen, P., Schelling, G., Birbaumer, M., Jäger, R., Bode, B., Studer, G., & Fuchs, B. (2024) · Cancers · doi:10.3390/cancers16142516 · Cited by 12
Advances and challenges in the origin and evolution of ovarian cancer organoids
Zhang, M., Yin, R., & Li, K. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1429141 · Cited by 12
Ahmad, I., Jasim, S. A., Sharma, M. K., Renuka Jyothi, S., Hjazi, A. M., Mohammed, J. S., Sinha, A., Zwamel, A. H., Hamzah, H. F., & Mohammed, B. A. (2024) · The Journal of Gene Medicine · doi:10.1002/jgm.3730 · Cited by 12
Biradar, S., Suresh, C., Nanjundeshwara, N., & Raghavan, R. (2024) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-7728-4.ch001 · Cited by 12
CAPTAIN: a multimodal foundation model pretrained on co-assayed single-cell RNA and protein
Ji, B., Hu, T., Wang, J., Liu, M., Xu, L., Zhang, Q., Zhong, S., Qiao, L., Zhang, Y., Peng, S., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-72882-y · Cited by 14
Naghib, S. M., Khorasani, M. A., Sharifianjazi, F., & Tavamaishvili, K. (2025) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2025.118412 · Cited by 11
Wang, M., An, K., Huang, J., Mprah, R., & Ding, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1193992 · Cited by 13
Li, L., Li, Y., Lu, M., Wang, Y., Li, Z., Hu, X., He, X., Gong, T., Luo, Y., Zhou, Y., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1235158 · Cited by 12
Particle uptake in cancer cells can predict malignancy and drug resistance using machine learning
Goldstein, Y., Cohen, O. T., Wald, O., Bavli, D., Kaplan, T., & Benny, O. (2024) · Science Advances · doi:10.1126/sciadv.adj4370 · Cited by 12
APOA1 mRNA and serum APOA1 protein as diagnostic and prognostic biomarkers in gastric cancer
Li, F., Han, M., Gao, X., Du, X., & Jiang, C. (2024) · Translational Cancer Research · doi:10.21037/tcr-23-1966 · Cited by 11
Computational modeling for medical data: From data collection to knowledge discovery
Yin, Y., Xu, S., Hong, Y., Cai, Y., Tang, W., Wang, J., Shen, B., Zong, H., & Yu, G. (2024) · The Innovation Life · doi:10.59717/j.xinn-life.2024.100079 · Cited by 11
Editorial: Integrative analysis for complex disease biomarker discovery
Huang, H., Li, J., & Cho, W. C. S. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1273084 · Cited by 11
Anoshkin, S., Shishkin, I. I., Markina, D. I., Logunov, L., Demir, H. V., Rogach, A. L., Pushkarev, A. P., & Makarov, S. (2024) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.3c03151 · Cited by 10
Roadmap for a European cancer data management and precision medicine infrastructure
Nikolski, M., Hovig, E. J., Al‐Shahrour, F., Blomberg, N., Scollen, S., Valencia, A., & Saunders, G. I. (2024) · Nature Cancer · doi:10.1038/s43018-023-00717-6 · Cited by 11
Ethical implications of blockchain technology in biomedical research
Rubeis, G. (2024) · Ethik in der Medizin · doi:10.1007/s00481-024-00805-w · Cited by 10
Big data in breast cancer: Towards precision treatment
Zhang, H., Hussin, H., Hoh, C.-C., Cheong, S.-H., Lee, W.-K., & Yahaya, B. H. (2024) · Digital Health · doi:10.1177/20552076241293695 · Cited by 13
Ahmed, M. K., Rozario, E., Mohonta, S. C., Ferdousmou, J., Saimon, A. S. M., Moniruzzaman, M., Manik, M. M. T. G., & Hasan, R. (2025) · Journal of Engineering · doi:10.1155/je/9928467 · Cited by 10
Mosku, N., Heesen, P., Christen, S., Scaglioni, M. F., Bode, B., Studer, G., & Fuchs, B. (2023) · Diagnostics · doi:10.3390/diagnostics13061206 · Cited by 10
Integrative big transcriptomics data analysis implicates crucial role of MUC13 in pancreatic cancer
Dhasmana, A., Dhasmana, S., Agarwal, S., Khan, S., Haque, S., Jaggi, M., Yallapu, M. M., & Chauhan, S. C. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.04.029 · Cited by 10
Florentino, B. R., Bonidia, R. P., Sanches, N. H., da Rocha, U. N., & de Carvalho, A. C. P. L. F. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.05.031 · Cited by 9
Li, F., Wang, X., Zhang, J., Jing, X., Zhou, J. A., Jiang, Q., Cao, L. H., Cai, S., Miao, J., Tong, D., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06827-y · Cited by 9
Toward Generative AI–Driven Metadata Modeling: A Human–Large Language Model Collaborative Approach
Bagchi, M. (2025) · Library trends · doi:10.1353/lib.2025.a961196 · Cited by 22
Advances and challenges in pathomics for liver cancer: From diagnosis to prognostic stratification
Peng, M.-H., Zhang, K., Guan, S.-W., Lin, Q. D., & Yu, H. (2025) · World Journal of Clinical Oncology · doi:10.5306/wjco.v16.i6.107646 · Cited by 9
Wang, Y., Gu, Y., Zhang, X., Wang, B., Wang, R., Li, X., Liu, Y., Qu, F., Ren, F., Yan, R., et al. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003790 · Cited by 9
Chen, J., Wang, G., Zhang, D., Luo, X., Zhang, D., & Zhang, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1075431 · Cited by 9
Self-Normalizing Foundation Model for Enhanced Multi-Omics Data Analysis in OncologyPreprint
Waqas, A., Tripathi, A. G., Ahmed, S., Mukund, A., Farooq, H., Johnson, J., Stewart, P., Naeini, M., Schabath, M. B., & Rasool, G. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.5055163 · Cited by 16
Yan, X., Qi, Y., Yao, X., Zhou, N., Ye, X., & Chen, X. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-04939-9 · Cited by 9
Mengzhen, Z., Xinwei, H., Zeheng, T., Li, N., Yang, Y., Huirong, Y., Kaisi, F., Ding, X., Liucheng, Y., & Wu, K. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05630-8 · Cited by 8
GTS: GPU-based Tree Index for Fast Similarity Search
Zhu, Y., Ma, R., Zheng, B., Ke, X., Chen, L., & Gao, Y. (2024) · Proceedings of the ACM on Management of Data · doi:10.1145/3654945 · Cited by 8
Lawlor, A., Beyer, K., Russell, B. A., Steinbeißer, C., Bjartell, A. S., Meulder, B. D., Omar, M. I., Hulsen, T., Butler, J., N’Dow, J., et al. (2024) · Nature Reviews Urology · doi:10.1038/s41585-024-00925-4 · Cited by 8
AI-Driven Chemometrics for Multi-omics Data Integration: Advances, Challenges, and Future Directions
Polu, P. R. (2026) · Critical Reviews in Analytical Chemistry · doi:10.1080/10408347.2026.2657553 · Cited by 9
Identification of a Novel Biomarker Panel for Breast Cancer Screening
Vaida, M. L., Arumalla, K. K., Tatikonda, P. K., Popuri, B., Bux, R. A., Tappia, P. S., Huang, G., Haince, J.-F., & Ford, W. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111835 · Cited by 8
Chilaca-Rosas, M.-F., Contreras-Aguilar, M.-T., Garcia-Lezama, M., Salazar-Calderon, D.-R., Vargas-Del-Angel, R.-G., Moreno‐Jiménez, S., Piña‐Sánchez, P., Trejo-Rosales, R. R., Delgado-Martinez, F.-A., & Roldán-Valadéz, E. (2023) · Diagnostics · doi:10.3390/diagnostics13162669 · Cited by 8
Mouse Stromal Cells Confound Proteomic Characterization and Quantification of Xenograft Models
Shi, Z., Mao, B., Chen, X., Hao, P., & Guo, S. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0431 · Cited by 7
Signature of exosomes in cancer translational medicine
Dhar, R., Kumarasamy, V., & Subramaniyan, V. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002413 · Cited by 7
Model‐based prediction of progression‐free survival for combination therapies in oncology
Baaz, M., Cardilin, T., & Jirstrand, M. (2023) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.13003 · Cited by 7
Rosa, S. C. D. S., Alizadeh, J., Vitorino, R. M. P., Surendran, A., Ravandi, A., Kidane, B., & Ghavami, S. (2024) · Methods in molecular biology · doi:10.1007/7651_2024_524 · Cited by 8
Prioritization of genes for translation: a computational approach
Rosa, S. C. D. S., Behrooz, A. B., Guedes, S. D. M., Vitorino, R. M. P., & Ghavami, S. (2024) · Expert Review of Proteomics · doi:10.1080/14789450.2024.2337004 · Cited by 7
TIMM17A overexpression in lung adenocarcinoma and its association with prognosis
Miao, L., Wu, D., Zhao, H., & Xie, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-59526-1 · Cited by 6
AI in Healthcare Data Analytics Trends and Transformative Innovations
Badiger, M., Adiga, S., Naik, A., Shetty, S., B., S. A., Mehnaz, F., & Singh, C. (2024) · Advances in healthcare information systems and administration book series · doi:10.4018/979-8-3693-7277-7.ch001 · Cited by 6
Current advances in comprehensive omics data mining for oncology and cancer research
Jeong, E., & Yoon, S. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189030 · Cited by 6
Artificial Intelligence, Big Data, and Regulation of Immunity: Challenges and Opportunities
Singh, B., Jevnikar, A. M., & Desjardins, E. (2024) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.2478/aite-2024-0006 · Cited by 6
Wang, A. (2024) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2024.00211 · Cited by 6
Çağlar, H. O., Aytatlı, A., Barlak, N., Karataş, E. A., Tatar, A. O., Şahin, A., & Karataş, Ö. F. (2024) · Head & Neck · doi:10.1002/hed.27803 · Cited by 6
Metadata
- Authors
- Jiang, P., Sinha, S., Aldape, K., Hannenhalli, S., Sahinalp, C., & Ruppin, E.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Jiang, Peng
- Ruppin, Eytan
- Venue
- Nature Reviews Cancer
- Published
- 2022-09-05
- Volume
- 22
- Issue
- 11
- Pages
- 625-639
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC9443637
- OpenAlex
- W4294636450
- Cited by
- 254
- References
- 188
- Citations by year
- 2026: 36 · 2025: 59 · 2024: 101 · 2023: 54 · 2022: 4
- FWCI
- 6.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Science, Research, and Medicine
- Keywords
- big data, cancer research, cancer omics, data integration, bioinformatics, artificial intelligence, biomarker discovery, clinical trials, cancer treatment development, high-throughput technologies
- MeSH terms
- Artificial Intelligence, Humans, Neoplasms, Computational Biology, Biomedical Research, Proteomics, Translational Research, Biomedical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review